期刊文献+

过氧化物酶蛋白1真核表达载体构建及在Hela细胞的表达与定位

Construction of Eukaryotic Expression Vector of Peroxiredoxin Ⅰ and its Expression and Localization in Hela Cells
原文传递
导出
摘要 目的:构建过氧化物酶蛋白1(PRDX 1)的真核表达载体,观察其在Hela细胞内表达及定位。方法:提取BALB/c小鼠肝脏组织总RNA,通过RT-PCR方法扩增得到小鼠PRDX 1编码序列,酶切后克隆至pcDNA3-myc载体。重组质粒通过PCR、酶切、测序证明构建正确后经脂质体转染Hela细胞,然后利用Western blot和荧光显微镜技术观察该融合蛋白在细胞内表达及定位。结果:经鉴定证明重组质粒构建正确;Western blot实验显示,该质粒能够在Hela细胞中特异表达;免疫荧光试验显示,蛋白产物分布在胞浆和胞核,证明该蛋白在细胞内高表达。结论:成功构建带有myc标签的PRDX 1真核表达载体,该质粒能够在哺乳细胞中特异表达并且外源性PRDX 1蛋白分布在Hela细胞胞浆胞核内,为深入研究PRDX 1蛋白在细胞内相关生物学研究奠定了基础。 Objective: To construct an eukaryotic vector of Peroxiredoxin 1(PRDX 1) and detect its expression and localization in Hela cells.Methods: The total RNA was extracted from the liver tissues of BALB/c mice,and the corresponding coding sequences of mouse PRDX 1 were amplified by RT-PCR,then they were cloned into the pcDNA3-myc vector to construct a new recombinant plasmid pcDNA3-PRDX 1-myc.The recombinant plasmid was verified by PCR,double digested by restriction endonuclease,and followed by sequencing.Subsequently,the correct construct was transfected into Hela cells with liposome transfection reagent Polyfect.The expression and localization of the fusion protein were detected by Western blot and fluorescence microscope.Results: The recombinant plasmid pcDNA3-PRDX 1-myc was correctly constructed.After transfection the recombinant plamid into Hela cells,the fusion protein was detected in Hela cells by Western blot and the fusion protein was founded in whole cells as shown by fluorescence microscopy.Conclusion: The eukaryotic expression vector for Prdx 1-myc fusion protein has been successfully constructed and effectively expressed in mammalian cells,and it can serve as an important tool for the further study of the correlated biological functions of PRDX 1 in eukaryotic cells.
出处 《现代生物医学进展》 CAS 2012年第14期2615-2618,共4页 Progress in Modern Biomedicine
基金 国家重大基础理论研究发展(973)计划项目(2010CB529704) 教育部长江学者和创新团队发展计划项目(IRT0731) 国家自然科学基金重点项目(81030055) 广东省自然基金项目(10251051501000003)
关键词 过氧化物酶1 分子克隆 蛋白表达定位 PRDX 1; Molecular cloning; Protein expression
  • 相关文献

参考文献20

  • 1Mizusawa H, Ishii T, Bannai S, et al. Peroxiredoxin 1 ( macro-phage 23 kDa stress protein) is highly and widely expressed in the rat nervous s- ystem[J]. Neurosci Lett, 2000, 283:57-60.
  • 2Rhee SG, Chae HZ, Kim K, et al. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling[J]. Free Radic Biol Med, 2005, 38:11-17.
  • 3Schroder E, Littlechild JA, Lebedev A, et al. Crystal structure of deca- meric 2-Cys peroxiredoxin from human erythrocytes at 1.7 A resoluti- on[J]. Structure Fold, Des, 2000, 8: 605- 615.
  • 4Bryk R, Griffin P, Nathan C. Peroxynitrite reductase activity of bacterial peroxiredoxins, Nature, 2000, 407:211-215.
  • 5Woo HA, Jeong W, Chang TS, et al. Reduction of cysteine sulfinic ac- id by sulfiredoxin is specific to 2-Cys peroxiredoxins[J]. J. Biol. Chem, 2005, 280:3125-3128.
  • 6Jang HH, Lee KO, Chi YH, et.al, Two enzymes in one, two yeast pero- xiredoxins display oxidative stress-dependent switching from a peroxi- dase to a molecular chaperone function[J]. Cell, 2004, 17:625-635.
  • 7Wood ZA, Poole LB, Karplus PA, et al. Peroxiredoxin evolution and t- he regulation of hydrogen peroxide signaling [J]. Science, 2003, 300: 650- 653.
  • 8Dierick JF, Wenders F, Chainiaux F, et al. Retrovirally mediated over- expression ofperoxiredoxin VI increases the survival of WI-38 human diploid fibroblasts exposed to cytotoxic doses of tert2butylhydroperox- ide and UVB[J]. Biogerontology, 2003, 4:125-131.
  • 9胡水旺,孙明晶,夏高晓,陈丽,赵明哲,姜勇.转甲状腺素蛋白真核表达载体的构建及其细胞内定位[J].解放军医学杂志,2009,34(6):722-724. 被引量:3
  • 10龚小卫,李涛,杨婷,李煜生,魏洁,邓鹏,姜勇.亚砷酸盐诱导HSP27的细胞内移位依赖于p38MAPK介导的磷酸化[J].中国生物化学与分子生物学报,2007,23(7):581-585. 被引量:2

二级参考文献26

  • 1Ando Y. Transthyretin-its function and pathogenesis. Rinsho Byori, 2006, 54 (5) : 497.
  • 2Maeedo B, Batista AR, do Amaral JB, et al. Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy. Mol Med, 2007, 13(11-12):584.
  • 3Fleming CE, Saraiva MJ, Sousa MM. Transthyretin enhances nerve regeneration, J Neurochem, 2007, 103(2) :831.
  • 4Kamata M, Susanto MT, Chen IS. Enhanced transthyretin tetramer stability following expression of an amyloid disease transsuppressor variant in mammalian cells. J Gene Med, 2009, 11(2):103.
  • 5Henze A, Rohn S, Gericke B, et al. Structural modifications of serum transthyretin in rats during protein-energy malnutrition. Rapid Commun Mass Spectrom, 2008, 22(20):3270.
  • 6Carriere I, Dupuy AM, Lacroux A, et al. Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people. J Am Geriatr Soc, 2008, 56(5):840.
  • 7Devakonda A, George L, Raoof S, et al. Transthyretin as a marker to predict outcome in critically ill patients. Clin Biochem, 2008, 41 (14 -15) :1126.
  • 8Schweigert FJ, Sehouli J. Transthyretin, a biomarker for nutritional status and ovarian cancer. Cancer Res, 2005, 65(3):1114.
  • 9Ando Y, Jono H. Pathogenesis and therapy for transthyretin related amyloidosis. Rinsho Byori, 2008, 56(2) :114.
  • 10Saraiva M:J, Birken S, Costa PP, et al. Amyloid fibril protein in familial amyloidofic polyneuropathy,Portuguese type. Definition of mo- lecular abnormality in transthyretin (prealbumin). J Clin Invest, 1984, 74(1) :104.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部